Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Fulfillment of Postmarketing Requirements to the FDA for Therapies Granted Oncology Indications Between 2011 and 2016

Fulfillment of Postmarketing Requirements to the FDA for Therapies Granted Oncology Indications... This data analysis examines the fulfillment of postmarketing requirements associated with drugs granted accelerated approval for oncology indications in the past 6 years. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Oncology American Medical Association

Fulfillment of Postmarketing Requirements to the FDA for Therapies Granted Oncology Indications Between 2011 and 2016

JAMA Oncology , Volume 4 (7) – Jul 10, 2018

Loading next page...
 
/lp/american-medical-association/fulfillment-of-postmarketing-requirements-to-the-fda-for-therapies-BAxQaYw1Hs
Publisher
American Medical Association
Copyright
Copyright 2018 American Medical Association. All Rights Reserved.
ISSN
2374-2437
eISSN
2374-2445
DOI
10.1001/jamaoncol.2018.0610
Publisher site
See Article on Publisher Site

Abstract

This data analysis examines the fulfillment of postmarketing requirements associated with drugs granted accelerated approval for oncology indications in the past 6 years.

Journal

JAMA OncologyAmerican Medical Association

Published: Jul 10, 2018

References